Companies NuVasive
NuVasive (NUVA): executive pay, fiscal 2022
Free brief. Every figure links to the company’s own filing.
NuVasive no longer files a proxy statement; its last pay data is FY2022.
CEO vs. named peers38th pct.Of 16 peer CEOs
CEO pay, last three years
- $4,819,006FY2020
- $7,632,250FY2021
- $8,077,095FY2022
CEO total pay was $8,077,095 in fiscal 2022, up from $7,632,250 in fiscal 2021.
FY2022: salary $896,635 · bonus $0 · stock awards $5,000,093 · option awards $0
Frequently asked questions
Who was the highest-paid executive at NuVasive in fiscal 2022?
As disclosed, J. Christopher Barry (Chief Executive Officer) was the highest-paid executive at NuVasive in fiscal 2022, with total compensation of $8,077,095.
How does NuVasive's chief executive pay compare to its disclosed peer group?
As disclosed, J. Christopher Barry's total compensation ranked at the 38th percentile of NuVasive's disclosed peer group.
What is NuVasive's CEO-to-median employee pay ratio?
As disclosed, NuVasive's CEO-to-median employee pay ratio was 118:1.
How did shareholders vote on NuVasive's executive compensation?
As disclosed, 52.2% of shareholders supported NuVasive's executive compensation in the latest say-on-pay vote.
How much does NuVasive spend in total on board compensation for fiscal 2022?
As disclosed, NuVasive reported total board compensation of $2,290,048 for fiscal 2022.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| J. Christopher Barry | $896,635 | $0 | $5,000,093 | $0 | $2,157,750 | $0 | $22,617 | $8,077,095 |
| Chief Executive Officer | ||||||||
| Matthew Harbaugh | 548,048 | 0 | 1,600,087 | 0 | 804,200 | 0 | 18,180 | 2,970,515 |
| Executive Vice President, Chief Financial Officer | ||||||||
| Massimo Calafiore | 329,327 | 0 | 1,200,092 | 0 | 0 | 0 | 19,219 | 1,548,638 |
| Former Executive Vice President, Chief Commercial Officer | ||||||||
| Nathaniel Sisitsky | 414,000 | 0 | 700,017 | 0 | 409,052 | 0 | 19,792 | 1,542,861 |
| Senior Vice President, General Counsel and Corporate Secretary | ||||||||
| Dale Wolf | 402,843 | 0 | 700,017 | 0 | 360,168 | 0 | 19,585 | 1,482,613 |
| Senior Vice President, Global Operations | ||||||||
| Michael Farrington | 327,115 | 50,000 | 400,103 | 0 | 239,129 | 0 | 10,216 | 1,026,563 |
| Senior Vice President, People and Culture | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2022 total | FY2021 total | FY2020 total | Δ FY2021→2022 |
|---|---|---|---|---|
| J. Christopher Barry | $8,077,095 | $7,632,250 | $4,819,006 | ↑ +444,845 |
| Matthew Harbaugh | 2,970,515 | 2,589,477 | 2,316,613 | ↑ +381,038 |
| Massimo Calafiore | 1,548,638 | 1,900,364 | 1,430,547 | ↓ −351,726 |
| Nathaniel Sisitsky | 1,542,861 | 1,513,006 | 1,119,976 | ↑ +29,855 |
| Dale Wolf | 1,482,613 | 1,379,263 | — | ↑ +103,350 |
| Michael Farrington | 1,026,563 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
The Company's executive compensation program is designed to attract, motivate and retain talented executives who drive the Company's success and enable long-term stockholder value creation by profitably growing the business, linking a significant portion of target compensation to performance-based results, and aligning compensation with both short- and long-term Company performance goals.
| CEO STI target (% of salary) | 125% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Frederic W. Cook & Co., Inc. |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2022
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Matthew Harbaugh | PSU | 2022-03-01 | 49 | 14,677 | — | 29,354 | $800,043 |
| Dale Wolf | PSU | 2022-03-01 | 21 | 6,421 | — | 12,842 | 350,009 |
| Michael Farrington | PSU | 2022-03-01 | 12 | 3,670 | — | 7,340 | 200,052 |
| J. Christopher Barry | RSU | 2022-03-01 | — | — | 45,864 | — | 2,500,047 |
| J. Christopher Barry | PSU | 2022-03-01 | 153 | 45,864 | — | 91,728 | 2,500,047 |
| Massimo Calafiore | PSU | 2022-03-01 | 37 | 11,008 | — | 22,016 | 600,046 |
| Nathaniel Sisitsky | PSU | 2022-03-01 | 21 | 6,421 | — | 12,842 | 350,009 |
| Massimo Calafiore | RSU | 2022-03-01 | — | — | 11,008 | — | 600,046 |
| Michael Farrington | RSU | 2022-03-01 | — | — | 3,670 | — | 200,052 |
| Matthew Harbaugh | RSU | 2022-03-01 | — | — | 14,677 | — | 800,043 |
| Nathaniel Sisitsky | RSU | 2022-03-01 | — | — | 6,421 | — | 350,009 |
| Dale Wolf | RSU | 2022-03-01 | — | — | 6,421 | — | 350,009 |
Vehicle mix — grant-date fair value by award type
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Matthew Harbaugh | $800,043 | $800,043 | $0 | 50.0% |
| Dale Wolf | 350,009 | 350,009 | 0 | 50.0% |
| Michael Farrington | 200,052 | 200,052 | 0 | 50.0% |
| J. Christopher Barry | 2,500,047 | 2,500,047 | 0 | 50.0% |
| Massimo Calafiore | 600,046 | 600,046 | 0 | 50.0% |
| Nathaniel Sisitsky | 350,009 | 350,009 | 0 | 50.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2022
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Michael Farrington | PSU | 6,574 | — | $271,112 |
| Michael Farrington | RSU | 10,745 | — | 443,124 |
| Dale Wolf | PSU | 14,397 | — | 593,732 |
| Nathaniel Sisitsky | PSU | 14,981 | — | 617,816 |
| Dale Wolf | RSU | 16,683 | — | 688,007 |
| Nathaniel Sisitsky | RSU | 17,647 | — | 727,762 |
| Matthew Harbaugh | PSU | 34,183 | — | 1,409,707 |
| Matthew Harbaugh | RSU | 41,564 | — | 1,714,099 |
| J. Christopher Barry | PSU | 101,205 | — | 4,173,694 |
| J. Christopher Barry | RSU | 118,347 | — | 4,880,630 |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Daniel J. WoltermanIndependent · Board Chair · Compensation (Chair) | $215,000 | $190,006 | — | — | $0 | $405,006 |
| Vickie L. CappsIndependent · Audit (Chair) · Nominating | 90,000 | 190,006 | — | — | 0 | 280,006 |
| Leslie V. NorwalkIndependent · Audit · Nominating (Chair) | 80,000 | 190,006 | — | — | 0 | 270,006 |
| Siddhartha C. KadiaIndependent · Nominating | 70,000 | 190,006 | — | — | 0 | 260,006 |
| John A. DeFordIndependent · Nominating | 70,000 | 190,006 | — | — | 0 | 260,006 |
| R. Scott HuennekensIndependent · Audit | 70,000 | 190,006 | — | — | 0 | 260,006 |
| Amy Belt RaimundoIndependent · Compensation | 70,000 | 190,006 | — | — | 0 | 260,006 |
| Robert F. FrielIndependent · Compensation | 70,000 | 190,006 | — | — | 0 | 260,006 |
| Donald J. RosenbergIndependent · Not standing for re-election · Departed during FY | 35,000 | 0 | — | — | 0 | 35,000 |
Board fee structure and ownership guideline
| Annual cash retainer | $70,000 |
|---|---|
| Annual equity retainer | $190,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 20,000 / 20,000 / 10,000 |
| Stock ownership guideline | 5x annual cash retainer ($350,000) |
Total cost of the board
| Component | FY2022 |
|---|---|
| Cash retainers and fees | $770,000 |
| Equity awards (grant-date value) | $1,520,048 |
| All other compensation | $0 |
| Total cost of the board | $2,290,048 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names NuVasive as a peer
Companies that benchmark against NUVA
1 company names NUVA as a compensation peer
The list of companies that name NUVA as a peer is temporarily unavailable — recheck shortly.
Disclosed peer group — fiscal year 2022
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
AVNS Avanos Medical, Inc.HAE Haemonetics CorporationLIVN LivaNova PLCOFIX Orthofix Medical, Inc.CNMD CONMED CorporationICUI ICU Medical, Inc.MASI Masimo CorporationQDEL QuidelOrtho CorporationDXCM Dexcom, Inc.ITGR Integer Holdings CorpMMSI Merit Medical Systems Inc.RMD ResMed, Inc.GMED Globus Medical, Inc.IART Integra LifeSciences Holdings CorpNVRO Nevro Corp.STE STERIS Plc
Peer reciprocity
The companies NuVasive names as compensation peers that name it back in their own disclosed peer groups.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Masimo Corporation | 2025 | Catherine Szyman | $850,048 | $16,388,693 | $1,399,998 | $1,130,000 | $19,797,140 |
| 2 | ResMed, Inc. | 2026 | Michael Farrell | 1,272,895 | 9,749,468 | 3,249,907 | 1,738,857 | 16,201,649 |
| 3 | Merit Medical Systems Inc. | 2025 | Fred Lampropoulos | 1,890,000 | 9,313,606 | 0 | 1,882,894 | 13,755,143 |
| 4 | Haemonetics Corporation | 2026 | Christopher Simon | 1,100,008 | 7,561,987 | 1,504,968 | 1,834,250 | 12,044,701 |
| 5 | Steris Plc | 2026 | Daniel Carestio | 1,095,707 | 4,333,951 | 4,334,251 | 1,725,007 | 11,508,522 |
| 6 | Nevro Corp. | 2023 | Kevin Thornal | 515,625 | 10,080,173 | 0 | 402,750 | 11,453,548 |
| 7 | QuidelOrtho Corporation | 2025 | Brian Blaser | 1,000,000 | 8,965,822 | 0 | 1,274,500 | 11,255,782 |
| 8 | Avanos Medical, Inc. | 2025 | David Pacitti | 751,705 | 7,000,000 | 0 | 1,148,667 | 9,469,803 |
| 9 | Integra LifeSciences Holdings Corp | 2025 | Mojdeh Poul | 1,009,616 | 5,219,868 | 2,250,011 | 174,563 | 9,375,551 |
| 10 | Integer Holdings Corp | 2025 | Joseph Dziedzic | 1,235,000 | 5,999,951 | 0 | 1,323,766 | 8,671,332 |
| 11 | NuVasive | 2022 | J. Christopher Barry | 896,635 | 5,000,093 | 0 | 2,157,750 | 8,077,095 |
| 12 | LivaNova PLC | 2025 | Vladimir Makatsaria | 956,115 | 4,303,092 | 1,374,999 | 1,287,656 | 8,047,217 |
| 13 | Dexcom, Inc. | 2025 | Jacob Leach | 768,962 | 5,936,062 | 0 | 1,164,780 | 7,985,960 |
| 14 | Conmed Corporation | 2025 | Patrick Beyer | 891,100 | 2,499,971 | 2,499,977 | 1,129,469 | 7,634,873 |
| 15 | Orthofix Medical, Inc. | 2025 | Massimo Calafiore | 848,322 | 4,499,988 | 1,500,009 | 445,579 | 7,310,039 |
| 16 | ICU Medical, Inc. | 2025 | Vivek Jain | 775,000 | 4,500,023 | 0 | 1,162,500 | 6,452,042 |
| 17 | Globus Medical, Inc. | 2025 | Keith Pfeil | 479,467 | 0 | 2,982,347 | 783,000 | 4,400,159 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Incentive design against the same peers
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| NuVasive | 75% | RSU 50 · PRSU 50 | No | Frederic W. Cook & Co., Inc. |
| Avanos Medical, Inc. | 139% | PSU 50 · RSU 25 · Options 25 | No | Meridian Compensation Partners |
| Conmed Corporation | 126.8% | Options 50 · PSU 50 | Yes — rTSR | Compensia, Inc. |
| Dexcom, Inc. | not disclosed | not disclosed | Yes — Relative TSR Performance Metric | Aon Hewitt Consulting Company |
| Globus Medical, Inc. | 102% | Options 100 | not disclosed | FW Cook |
| Haemonetics Corporation | 133.4% | PSU 60 · RSU 20 · Options 20 | Yes — Relative Total Shareholder Return (rTSR) | Pearl Meyer & Partners, LLC |
| ICU Medical, Inc. | 150% | PSU 50 · RSU 50 | No | Compensia |
| Integer Holdings Corp | 85.75% | PSU 66 · RSU 34 | Yes — Relative TSR versus peer group | FW Cook |
| Integra LifeSciences Holdings Corp | 40% | PSU 50 · Options 25 · RSU 25 | No | WTW |
| LivaNova PLC | 122.4% | PSU 50 · RSU 25 · Options 25 | No | Pearl Meyer |
| Masimo Corporation | not disclosed | not disclosed | not disclosed | FW Cook |
| Merit Medical Systems Inc. | 124.53% | PSU 60 · RSU 40 | Yes — Relative Total Shareholder Return (rTSR) | Pearl Meyer & Partners, LLC |
| Nevro Corp. | 53.7% | not disclosed | No | Aon |
| Orthofix Medical, Inc. | 47.7% | PSU 50 · Option 25 · RSU 25 | No | Meridian |
| QuidelOrtho Corporation | not disclosed | PSU 60 · RSU 40 | Yes — Total Shareholder Return (TSR) | Compensia |
| ResMed, Inc. | not disclosed | PSU 50 · RSU 25 · Options 25 | Yes — Relative TSR | FW Cook |
| Steris Plc | 125.1% | Option 50 · Restricted Stock 50 | not disclosed | Frederic W. Cook & Co., Inc. |
Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2023 | 2023-06-09 | 23,280,243 | 21,316,819 | 25,361 | 52.2% | Passed |
| 2022 | 2022-05-11 | 41,289,859 | 1,553,266 | 53,244 | 96.37% | Passed |
| 2021 | 2021-05-18 | 44,840,599 | 1,012,102 | 45,246 | 97.79% | Passed |
| 2019 | 2019-05-09 | 40,178,486 | 3,666,595 | 341,865 | 90.93% | Passed |
| 2018 | 2018-05-03 | 38,884,347 | 4,413,595 | 232,604 | 89.33% | Passed |
| 2017 | 2017-05-18 | 40,303,250 | 3,834,584 | 97,252 | 91.11% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2023 | 2023-06-09 | 52.2%a |
| 2022 | 2022-05-11 | 96.37%b |
| 2021 | 2021-05-18 | 97.79%c |
a. Voting standard not stated in the filing.
b. Approved under the standard stated in the filing — “Proposal 3—Annual "Say-on-Pay" Vote -- Majority of Votes Cast”.
c. Approved under the standard stated in the filing — “Proposal 3—Annual "Say-on-Pay" Vote -- Majority of Votes Cast”.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
CEO pay ratio
| Ratio (CEO : median employee) | 118 : 1 |
|---|---|
| CEO total compensation | $8,077,095 |
| Median employee compensation | $68,396 |
Insider trades since the proxy
No insider equity transactions reported since the proxy statement.
Sources (52 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, J. Christopher Barry. DEF 14A, filed 2023-05-08. Section “2022 Summary Compensation Table”. As printed: 8,077,095. View filing ↗
- Section 01, Matthew Harbaugh. DEF 14A, filed 2023-05-08. Section “2022 Summary Compensation Table”. As printed: 2,970,515. View filing ↗
- Section 01, Massimo Calafiore. DEF 14A, filed 2023-05-08. Section “2022 Summary Compensation Table”. As printed: 1,548,638. View filing ↗
- Section 01, Nathaniel Sisitsky. DEF 14A, filed 2023-05-08. Section “2022 Summary Compensation Table”. As printed: 1,542,861. View filing ↗
- Section 01, Dale Wolf. DEF 14A, filed 2023-05-08. Section “2022 Summary Compensation Table”. As printed: 1,482,613. View filing ↗
- Section 01, Michael Farrington. DEF 14A, filed 2023-05-08. Section “2022 Summary Compensation Table”. As printed: 1,026,563. View filing ↗
- Section 03, Matthew Harbaugh PSU. DEF 14A, filed 2023-05-08. Section “Grants of Plan-Based Awards for 2022” · grants of plan-based awards table. View filing ↗
- Section 03, Dale Wolf PSU. DEF 14A, filed 2023-05-08. Section “Grants of Plan-Based Awards for 2022” · grants of plan-based awards table. View filing ↗
- Section 03, Michael Farrington PSU. DEF 14A, filed 2023-05-08. Section “Grants of Plan-Based Awards for 2022” · grants of plan-based awards table. View filing ↗
- Section 03, J. Christopher Barry RSU. DEF 14A, filed 2023-05-08. Section “Grants of Plan-Based Awards for 2022” · grants of plan-based awards table. View filing ↗
- Section 03, J. Christopher Barry PSU. DEF 14A, filed 2023-05-08. Section “Grants of Plan-Based Awards for 2022” · grants of plan-based awards table. View filing ↗
- Section 03, Massimo Calafiore PSU. DEF 14A, filed 2023-05-08. Section “Grants of Plan-Based Awards for 2022” · grants of plan-based awards table. View filing ↗
- Section 03, Nathaniel Sisitsky PSU. DEF 14A, filed 2023-05-08. Section “Grants of Plan-Based Awards for 2022” · grants of plan-based awards table. View filing ↗
- Section 03, Massimo Calafiore RSU. DEF 14A, filed 2023-05-08. Section “Grants of Plan-Based Awards for 2022” · grants of plan-based awards table. View filing ↗
- Section 03, Michael Farrington RSU. DEF 14A, filed 2023-05-08. Section “Grants of Plan-Based Awards for 2022” · grants of plan-based awards table. View filing ↗
- Section 03, Matthew Harbaugh RSU. DEF 14A, filed 2023-05-08. Section “Grants of Plan-Based Awards for 2022” · grants of plan-based awards table. View filing ↗
- Section 03, Nathaniel Sisitsky RSU. DEF 14A, filed 2023-05-08. Section “Grants of Plan-Based Awards for 2022” · grants of plan-based awards table. View filing ↗
- Section 03, Dale Wolf RSU. DEF 14A, filed 2023-05-08. Section “Grants of Plan-Based Awards for 2022” · grants of plan-based awards table. View filing ↗
- Section 07, pay ratio. DEF 14A, filed 2023-05-08. Section “CEO Pay Ratio”. As printed: 118 : 1. View filing ↗
- Section 08, Daniel J. Wolterman. DEF 14A, filed 2023-05-08. Section “Director Compensation”. As printed: 405,006. View filing ↗
- Section 08, Vickie L. Capps. DEF 14A, filed 2023-05-08. Section “Director Compensation”. As printed: 280,006. View filing ↗
- Section 08, Leslie V. Norwalk. DEF 14A, filed 2023-05-08. Section “Director Compensation”. As printed: 270,006. View filing ↗
- Section 08, Siddhartha C. Kadia. DEF 14A, filed 2023-05-08. Section “Director Compensation”. As printed: 260,006. View filing ↗
- Section 08, John A. DeFord. DEF 14A, filed 2023-05-08. Section “Director Compensation”. As printed: 260,006. View filing ↗
- Section 08, R. Scott Huennekens. DEF 14A, filed 2023-05-08. Section “Director Compensation”. As printed: 260,006. View filing ↗
- Section 08, Amy Belt Raimundo. DEF 14A, filed 2023-05-08. Section “Director Compensation”. As printed: 260,006. View filing ↗
- Section 08, Robert F. Friel. DEF 14A, filed 2023-05-08. Section “Director Compensation”. As printed: 260,006. View filing ↗
- Section 08, Donald J. Rosenberg. DEF 14A, filed 2023-05-08. Section “Director Compensation”. As printed: 35,000. View filing ↗
- Section 06, 2023 vote. Form 8-K, filed 2023-06-09. Item 5.07 · say-on-pay result. As reported: 52.2% (votes for as printed: 23,280,243). View filing ↗
- Section 06, 2022 vote. Form 8-K, filed 2022-05-12. Item 5.07 · say-on-pay result. As reported: 96.37% (votes for as printed: 41,289,859). View filing ↗
- Section 06, 2021 vote. Form 8-K, filed 2021-05-19. Item 5.07 · say-on-pay result. As reported: 97.79% (votes for as printed: 44,840,599). View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
- Section 09b board cost (computed). Computed. Cash 770,000 + equity 1,520,048 + all other 0 = 2,290,048, summed across the director compensation table rows.
- Masimo Corporation, Section 10b CEO total. 10-K/A, filed 2026-05-01. CEO total compensation as printed in Masimo Corporation's own proxy. As printed: 19,797,140. View filing ↗
- ResMed, Inc., Section 10b CEO total. DEF 14A, filed 2026-10-01. CEO total compensation as printed in ResMed, Inc.'s own proxy. As printed: 16,201,649. View filing ↗
- Merit Medical Systems Inc., Section 10b CEO total. DEF 14A, filed 2026-03-31. CEO total compensation as printed in Merit Medical Systems Inc.'s own proxy. As printed: 13,755,143. View filing ↗
- Haemonetics Corporation, Section 10b CEO total. DEF 14A, filed 2026-06-09. CEO total compensation as printed in Haemonetics Corporation's own proxy. As printed: 12,044,701. View filing ↗
- Steris Plc, Section 10b CEO total. DEF 14A, filed 2026-06-11. CEO total compensation as printed in Steris Plc's own proxy. As printed: 11,508,522. View filing ↗
- Nevro Corp., Section 10b CEO total. DEF 14A, filed 2024-04-12. CEO total compensation as printed in Nevro Corp.'s own proxy. As printed: 11,453,548. View filing ↗
- QuidelOrtho Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-27. CEO total compensation as printed in QuidelOrtho Corporation's own proxy. As printed: 11,255,782. View filing ↗
- Avanos Medical, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-12. CEO total compensation as printed in Avanos Medical, Inc.'s own proxy. As printed: 9,469,803. View filing ↗
- Integra LifeSciences Holdings Corp, Section 10b CEO total. DEF 14A, filed 2026-04-06. CEO total compensation as printed in Integra LifeSciences Holdings Corp's own proxy. As printed: 9,375,551. View filing ↗
- Integer Holdings Corp, Section 10b CEO total. DEF 14A, filed 2026-04-06. CEO total compensation as printed in Integer Holdings Corp's own proxy. As printed: 8,671,332. View filing ↗
- NuVasive (subject), Section 10b CEO total. DEF 14A, filed 2023-05-08. CEO total compensation as printed in NuVasive's own proxy. As printed: 8,077,095. View filing ↗
- LivaNova PLC, Section 10b CEO total. DEF 14A, filed 2026-04-29. CEO total compensation as printed in LivaNova PLC's own proxy. As printed: 8,047,217. View filing ↗
- Dexcom, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-15. CEO total compensation as printed in Dexcom, Inc.'s own proxy. As printed: 7,985,960. View filing ↗
- Conmed Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-07. CEO total compensation as printed in Conmed Corporation's own proxy. As printed: 7,634,873. View filing ↗
- Orthofix Medical, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-29. CEO total compensation as printed in Orthofix Medical, Inc.'s own proxy. As printed: 7,310,039. View filing ↗
- ICU Medical, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-02. CEO total compensation as printed in ICU Medical, Inc.'s own proxy. As printed: 6,452,042. View filing ↗
- Globus Medical, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-24. CEO total compensation as printed in Globus Medical, Inc.'s own proxy. As printed: 4,400,159. View filing ↗
- Section 10a, Nevro Corp. reciprocity. DEF 14A. Nevro Corp. names NuVasive in its own disclosed peer group (read from its most recent proxy). View filing ↗